Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of Sorafenib in Malignant Mesothelioma Previously Treated With Platinum-based Chemotherapy

NCT00794859 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT00794859
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00794859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of Sorafenib in Malignant Mesothelioma Previously Treated With Platinum-based Chemotherapy
Lead sponsor
King's College London
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2008
Completion date
Not reported
Enrollment
54 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mesothelioma